PYRAZOLOPYRIMIDINONE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT Russian patent published in 1998 - IPC

Abstract RU 2114114 C1

FIELD: organic chemistry, heterocyclic compounds, biochemistry. SUBSTANCE: products: new derivatives of pyrazolo-[4,3-d]-pyrimidine-7-one of the formula (I) where R1 - H, CH3,C2H5; R2 - CH3,CH2OH,CH2OCH3 or n-C3H7; R3 - C2H5, CH2=CH-CH2; R4 together with nitrogen atom to which it is bound forms 4-R5-piperidino- or 4-N-(R6)-piperazyl group; R5 - H, N-(CH3)2,CONH2; R6 - H, CH3, i-C3H7,CH2CH2OH,CSNH2,C(NH)NHCH3 or C(NH)S-CH3, and their pharmaceutically acceptable salts. Invention relates to also pharmaceutical composition showing inhibitory activity with respect to cyclic guanosine-3',5'-monophosphate phosphodiesterase that has 1-400 mg of compound of the formula (I) per a single dose in mixture with pharmaceutically acceptable vehicle or carrier. Invention relates to also a method of treatment or prophylaxis of states caused by phosphodiesterase activity by prescription to human an effective dose of compound of the formula (I) or its pharmaceutically acceptable salt of above indicated composition. Invention relates to also intermediate compounds of formulas (II) and (IV) where R1,R2,R3 have values given above. In compounds of the formula (II) radical R3 can mean atom H and Y - atom Cl. EFFECT: improved method of synthesis of new compounds, enhanced effectiveness. 9 cl, 2 tbl

Similar patents RU2114114C1

Title Year Author Number
METHOD OF SYNTHESIS OF PYRAZOLOPYRIMIDINE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1991
  • Ehndrju Sajmon Bell[Gb]
  • Dehvid Braun[Gb]
  • Nikolas Kennet Terrett[Gb]
RU2047617C1
PYRAZOLOPYRIMIDINONES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF CYCLIC GUANOSINE-3',5'-MONOPHOSPHATE PHOSPHODIESTERASE 1992
  • Ehndrju Simon Bell
  • Nikolas Kennet Terrett
RU2114113C1
PYRAZOLEPYRIMIDINONES FOR TREATMENT OF IMPOTENTS 1994
  • Piter Ehllis
  • Nikolas Kennet Terrett
RU2130776C1
IMPROVED METHOD FOR PREPARING 5-[2-ETHOXY-5-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYL]-1-METHYL-N-PROPYL-1, 6-DIHYDRO-7H-PYRAZIL[4,3-D]PYRIMIDINE-7-ONE 2003
  • Modi Shirish Bkhagvanlal
  • Doshi Madkhukant Mansukkhlal
  • Shrikande Atul Anant
RU2239637C1
PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1993
  • Jukhping Liang Chen
RU2124016C1
PYRIDINE DERIVATIVES CONDENSED WITH HETEROCYCLE 1996
  • Li Daniel Arnol'D
  • Mikel Pol Mojer
  • S'Juzan Bet Sobolov-Dzhejniz
RU2136683C1
PIRAZILE PYRIMIDINONES FOR IMPOTENCY TREATMENT 1994
  • Ehllis Piter
  • Terrett Nikolas Kennet
RU2373938C9
TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO-[3,4-C]-1,2,4-TRIAZOLO- -[4,3-A]-PYRIDINES, METHOD OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE TYPE IV AND METHOD OF INHIBITION OF TUMOR-SPECIFIC NECROSIS FACTOR PRODUCING 1996
  • Allen Jakob Daplehntir
  • Kelvin Kuper
RU2161158C2
DERIVATIVES OF PYRROLO[2,3-D]PYRIMIDINES, PHARMACEUTICAL COMPOSITION, PYRROLO[2,3-D]PYRIMIDINES, DERIVATIVES OF PYRROLE 1993
  • Jukhping L.Chen
RU2124015C1
PROCESS FOR PREPARING SUBSTITUTED N-(5-TETRASOLYL)-1-KETO-1H-TRIAZOLE (3,2-ALPHA) PYRIMIDINE-2-CARBOXAMIDES OR THEIR SALTS (MODIFICATIONS) 0
  • Sol Bernard Kejdin
SU1042620A3

RU 2 114 114 C1

Authors

Ehndrju Simon Bell

Dehvid Braun

Nikolas Kennet Terrett

Dates

1998-06-27Published

1991-06-19Filed